⚠ FOLD is no longer actively traded. Data shown reflects verified historical relationships.
Supply Chain Intelligence

Amicus Therapeutics Inc Supply Chain

FOLD supply chain intelligence for Amicus Therapeutics Inc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

FOLD ·Last updated 2026-07-01 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
1Customers
3Debt Items
20Related Chains

Amicus Therapeutics Inc Suppliers

TickerNameConfidenceEvidence
WUXI WUXI 92% We currently rely on WuXi, as the primary supplier of our biologic product, Pombiliti ® .
BLACKSTONE-ALTERNATIVE-CREDIT-ADVISORS-LP BLACKSTONE-ALTERNATIVE-CREDIT-ADVISORS-LP 90% the Company repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all commitments under that certain Loan Agreement, dated October 2, 2023, (as amended, res…
BLACKSTONE-LIFE-SCIENCES-ADVISORS-L-L-C BLACKSTONE-LIFE-SCIENCES-ADVISORS-L-L-C 90% the Company repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all commitments under that certain Loan Agreement, dated October 2, 2023, (as amended, res…
WILMINGTON-TRUST-NATIONAL-ASSOCIATION WILMINGTON-TRUST-NATIONAL-ASSOCIATION 90% the Company repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all commitments under that certain Loan Agreement, dated October 2, 2023, (as amended, res…

Amicus Therapeutics Inc Customers

TickerNameConfidenceEvidence
LYNX-MERGER-SUB-1-INC LYNX-MERGER-SUB-1-INC 92% Amicus Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), dated December 19, 2025, with BioMarin Pharmaceutical Inc…

Amicus Therapeutics Inc Debt Obligations

InstrumentDescriptionConfidenceEvidence
FOLD-DEBT-9610 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
FOLD-DEBT Debt stack $442.4M 90% Market cache reports total debt of $442.4M.
FOLD-DEBT-9609 Warrants outstanding: 1600000 90% xbrl warrant detail from xbrl 2025-12-31.

Amicus Therapeutics Inc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Amicus Therapeutics Inc.

Amicus Therapeutics Inc Ownership

HolderNameConfidenceEvidence
FOLD-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 304 tracked holders.

Amicus Therapeutics Inc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
View FOLD supply chain intel →

Explore the full interactive supply chain map for Amicus Therapeutics Inc.

Open FOLD supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map